Diagnostics News and Research

RSS

New UK supply contract for COVID-19 sample collection kits

EKF Diagnostics Holdings plc, the AIM listed point-of-care business, announces that it has received an initial order worth £3 m from a partner from the private sector to supply PrimeStore MTM, a novel patented sample collection device, to be used in a COVID-19 testing programme for UK staff.

From EKF Diagnostics 5 Aug 2020

Panthera’s oncology clinical trial sites in the UK are open for research activities

Over a thousand oncology clinical trials have been suspended due to Covid putting back research which is vital for patients across the world.

5 Aug 2020

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which will be conducted by the ACTG.

4 Aug 2020

Russian researchers suggest device to improve breast MRI

Magnetic resonance imaging is becoming increasingly popular as a method of diagnosing diseases. Standard scanners are multifunctional, making it possible to cut down on the costs of specialized equipment.

4 Aug 2020

Meningitis case at Children's National Hospital raises concerns about antibiotic resistance

A recent meningitis case at Children's National Hospital raises serious concerns about antibiotic resistance in the common bacterium that caused it, researchers from the hospital write in a case report.

3 Aug 2020

Synthetic riboregulators detect SARS-CoV-2 genome parts in 40 minutes

By exploiting the tools of synthetic biology, the researchers from Turkey have successfully developed a de novo riboregulator system for rapidly detecting the presence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic material. Their paper is currently available on medRxiv preprint server.

2 Aug 2020

Emergency Committee on COVID-19 highlights the need for sustained global response efforts

The Emergency Committee on COVID-19, convened by the WHO Director-General under the International Health Regulations (2005) (IHR), held its fourth meeting on 31 July. In its statement following the meeting, published today, it expressed "appreciation for WHO and partners' COVID-19 pandemic response efforts, and highlighted the anticipated lengthy duration of this COVID-19 pandemic, noting the importance of sustained community, national, regional, and global response efforts."

1 Aug 2020

FDA authorizes first two COVID-19 serology tests

Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual's blood.

1 Aug 2020

NIH invests $248.7 million in new COVID-19 testing technologies to meet U.S. demand

The National Institutes of Health is investing $248.7 million in new technologies to address challenges associated with COVID-19 testing (which detects SARS-CoV-2 coronavirus).

31 Jul 2020

A cheaper and rapid pooling strategy for RT-PCR-based detection of SARS-CoV-2

In a report in the Journal of Molecular Diagnostics, published by Elsevier, researchers at Augusta University and PerkinElmer Genomics describe a cheaper, rapid, and accurate pooling strategy for the RT-PCR-based detection of SARS-CoV-2 in clinical samples.

31 Jul 2020

'Drawn-on-skin' electronics enable collection of more precise, motion artifact-free health data

A team of researchers led by Cunjiang Yu, Bill D. Cook Associate Professor of Mechanical Engineering at the University of Houston, has developed a new form of electronics known as "drawn-on-skin electronics," allowing multifunctional sensors and circuits to be drawn on the skin with an ink pen.

30 Jul 2020

CZI, CZ Biohub, and The State Of California join forces to track COVID-19 transmission

Today, the Chan Zuckerberg Biohub, in partnership with the Chan Zuckerberg Initiative, announced that it will provide free whole genome sequencing and analysis of the SARS-CoV-2 virus to all California Departments of Public Health and California local health jurisdictions through a newly-launched effort called the California COVID Tracker.

30 Jul 2020

Patent issued for Concarlo-developed therapeutic peptide to treat drug-resistant breast cancer

Concarlo Holdings LLC, has today announced that US Patent 10,702,570 was issued by the United States Patent and Trademark Office on July 07, 2020, marking the latest step in Concarlo’s journey to commercialize revolutionary medicines for metastatic breast cancer.

30 Jul 2020

First 3D multicellular brain organoid can screen drugs to control inflammation

The scientists who developed the first 3D multicellular brain organoid with a functional blood brain barrier now report that the model could be a promising platform to screen drugs that could work to control inflammation, which is at the center of many neurological conditions, like ischemic stroke.

30 Jul 2020

New edition of trilateral study on access to medical technologies and innovation launched

On 29 July, the Directors-General of the World Health Organization, the World Intellectual Property Organization and the WTO presented a new edition of the Trilateral Study on Access to Medical Technologies and Innovation.

29 Jul 2020

WHO and NDWG launch framework for evaluation of new tests for TB infection

WHO and the Stop TB Partnership's New Diagnostics Working Group launched today a framework for the evaluation of new tests for tuberculosis infection.

29 Jul 2020

COVID-19 test kits offered by Carolina Liquid Chemistries granted FDA emergency use authorization

Carolina Liquid Chemistries, Corp., an innovative leader in clinical diagnostics and drug screening, is now offering test kits for COVID-19 that have been granted Emergency Use Authorization by the US Food and Drug Administration, pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act.

From Carolina Liquid Chemistries Corp. 29 Jul 2020

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy

Avacta Group plc, is pleased to announce an expansion of its collaboration and license agreement with Daewoong Pharmaceutical Co.Ltd and AffyXell Therapeutics.

29 Jul 2020

Scientists are developing AI tools that can benefit certain cancer patients

Case Western Reserve University scientists are developing artificial intelligence (AI) tools to help surgeons and oncologists identify the subtle but critical differences between a recurring tumor and damaged non-cancerous tissue on post-operative MRI scans of certain cancer patients.

29 Jul 2020

Computed tomography can serve as effective tool for diagnosing COVID-19

The use of computed tomography in outpatient computed tomography centers (OCTC) is entirely consistent with the clinical data and global best practices. This is also an effective tool for diagnosing the coronavirus infection COVID-19

29 Jul 2020

Diagnostics News and Research

New UK supply contract for COVID-19 sample collection kits

Panthera’s oncology clinical trial sites in the UK are open for research activities

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

Russian researchers suggest device to improve breast MRI

Meningitis case at Children's National Hospital raises concerns about antibiotic resistance

Synthetic riboregulators detect SARS-CoV-2 genome parts in 40 minutes

Emergency Committee on COVID-19 highlights the need for sustained global response efforts

FDA authorizes first two COVID-19 serology tests

NIH invests $248.7 million in new COVID-19 testing technologies to meet U.S. demand

A cheaper and rapid pooling strategy for RT-PCR-based detection of SARS-CoV-2

'Drawn-on-skin' electronics enable collection of more precise, motion artifact-free health data

CZI, CZ Biohub, and The State Of California join forces to track COVID-19 transmission

Patent issued for Concarlo-developed therapeutic peptide to treat drug-resistant breast cancer

First 3D multicellular brain organoid can screen drugs to control inflammation

New edition of trilateral study on access to medical technologies and innovation launched

WHO and NDWG launch framework for evaluation of new tests for TB infection

COVID-19 test kits offered by Carolina Liquid Chemistries granted FDA emergency use authorization

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy

Scientists are developing AI tools that can benefit certain cancer patients

Computed tomography can serve as effective tool for diagnosing COVID-19

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News